Anemia of Prematurity, Intraventricular Hemorrhage, Prematurity, Respiratory Distress Syndrome
Conditions
Keywords
Preterm neonates., Autologous cord blood transfusion.
Brief summary
This is a pilot study to test feasibility of collection, preparation and infusion of a baby's own (autologous) umbilical cord blood in the first 14 days after birth if the baby is born premature \<35 weeks of gestation.
Detailed description
In Egypt, 12-15.8% of live neonates are low birth weight and it is estimated that about one third of such infants are preterm \[1\] (UNICEF, 2001). In a study that Campbell et al. (2004) conducted in Egypt, the neonatal mortality rate was estimated to be 25 per 1000 live births. prematurity was considered the main cause of neonatal deaths (39%), followed by asphyxia (18%), infection (7%), especially in the late neonatal period, and congenital malformations (6%). A substantial proportion (29%) could not be classified \[2\]. In developing countries, prematurity was the main cause of early neonatal deaths (62%)\[3\] Autologous cord blood transfusion will be safe, and cheap. The preterm neonates need transfusion of whole blood or any of its components at a time during NICU admission.
Interventions
BIOLOGICALAutologous cord blood transfusion for preterm neonates
Cord blood collection after delivery of the baby. Preservation of blood in blood bank. Transfusion of blood within the first 14 postnatal days to maintain Hb level above 10gm%.
BIOLOGICALAutologous cord blood transfusion
After delivery of the baby and before placental delivery in vaginal delivery. After delivery of the baby the placental will be taken out in cesarean section. sterilization of the umbilical cord will be done. Puncture of the umbilical cord vein with the needle of blood transfusion bag will be done. Blood will be kept in the blood bank. Blood grouping, haematocrit and CBC will be done for the cord blood.Maternal sample will be analysed simultaneously. Mononuclear layer will be separated within 6 hours and transfused to the preterm neonate immediately. RBCs will be separated and kept till need (Hb less than 10 gm%).
Sponsors
Sahar M.A. Hassanein, MD
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
1 Days to 30 Days
Healthy volunteers
No
Inclusion criteria
* Preterm neonates less than 34 weeks of gestation. * Low birth weight less than 1500 grams
Exclusion criteria
* Congenital malformations. * Suspected inborn error of metabolism. * Suspected inherited neurologic disease.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Duration of mechanical ventilation | 30 days | -No need for mechanical ventilation. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Survival | 18 months | * Survival until 12 months of age. * Improved physical growth and weight gain. * Neurodevelopmental outcome at 6, 12 and 18 months of age. |
Countries
Egypt
Outcome results
None listed